-+ 0.00%
-+ 0.00%
-+ 0.00%

ADIAL PHARMACEUTICALS: IMPLEMENTING FDA'S RECOMMENDATIONS BASED ON EOP2 MEETING, TO ADVANCE AD04 TOWARD PHASE 3 DEVELOPMENT

Reuters·11/14/2025 13:30:02

Please log in to view news